NY A05562

Prohibits pharmacists from substituting any anti-epileptic drug without prior notification and signed informed consent from both the prescribing physician and the patient (or patient's parent, guardian, or spouse)

Defines "interchange" broadly to include substituting generic for brand, brand for generic, different manufacturers' generics, different formulations, or different anti-epileptic products than originally prescribed

Defines anti-epileptic drugs as any drug prescribed for epilepsy treatment or used to treat or prevent seizures

Creates an exception to existing pharmacy law that otherwise requires pharmacists to substitute less expensive equivalent drugs when available

Takes effect immediately upon passage